Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital,

Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital,

Biotech Health services

Sweden

Spain

Switzerland

Germany

France

United States

Belgium

Investments

03 October 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Tubulis (company)

Germany

Biotech Health services

Total investments received (USD): 618.84M

Round value (USD): 361.28M

Round investors: EQT Partners Bayern Kapital Ascenta Capital Wellington Management Nextech Invest Andera Partners Frazier Life Sciences Deep Track Capital Fundplus High-Tech Gründerfonds Mutua Madrileña OCCIDENT Seventure Partners Venrock

Company: Tubulis

Industry: Biotech Health services

Related deals

Black Forest raised a $300M Series B led by AMP and Salesforce VC, joined by a16z, BroadLight, Creandum, Earlybird VC, General Catalyst, Northzone

AI (big data) Media Audio Software Services Video

Sweden

Norway

Germany

France

United Kingdom

United States

Poland

Belgium

Singapore

Argentina

Investments 30 November 2025

Quantum Systems in a €180 million series C extension funding round led by Balderton Capital

Airline Industry Automotive Manufacturing Security Transportation

Germany

United Kingdom

United States

Investments 10 November 2025

AAVantgarde Bio to raise $141M series B co-led by Schroders Capital with existing investors Atlas Venture and Forbion

Biotech Health services

Spain

France

United Kingdom

Netherlands

United States

Italy

Canada

Investments 19 October 2025

Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest

Biotech Health services

Denmark

Sweden

France

United States

Investments 16 October 2025

ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion

Biotech Health services Pharma

France

M&A 12 October 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top